Orcutt, Xavier https://orcid.org/0009-0005-3024-8298
Chen, Kan
Mamtani, Ronac https://orcid.org/0000-0002-8267-5356
Long, Qi https://orcid.org/0000-0003-0660-5230
Parikh, Ravi B. https://orcid.org/0000-0003-2692-6306
Article History
Received: 12 March 2024
Accepted: 10 October 2024
First Online: 3 January 2025
Competing interests
: The authors have no competing interests related to the content of this work. R.B.P. has received grants from the National Institutes of Health, the US Department of Defense, the Prostate Cancer Foundation, the National Palliative Care Research Center, the NCCN Foundation, the Conquer Cancer Foundation, Humana, Emerson Collective, Schmidt Futures, Arnold Ventures, Mendel.ai and the Veterans Health Administration; personal fees and equity from GNS Healthcare, Thyme Care and Onc.AI; personal fees from ConcertAI, Cancer Study Group, Biofourmis, Genetic Chemistry Therapeutics, CreditSuisse, G1 Therapeutics, Humana and Nanology; and honoraria from Flatiron and Medscape. R.B.P. also has board memberships (unpaid) at the Coalition to Transform Advanced Care and the American Cancer Society and serves on a leadership consortium (unpaid) at the National Quality Forum, all outside the submitted work.